ArticlePloS one2013

Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin.

Stephanie Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.